This company listing is no longer active
Biodexa Pharmaceuticals Management
Management criteria checks 4/4
Key information
Stephen Stamp
Chief executive officer
UK£237.9k
Total compensation
| CEO salary percentage | 99.4% |
| CEO tenure | 3.6yrs |
| CEO ownership | 0.003% |
| Management average tenure | 2.3yrs |
| Board average tenure | 6yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -UK£5m |
| Mar 31 2022 | n/a | n/a | -UK£5m |
| Dec 31 2021 | UK£329k | UK£187k | -UK£5m |
| Sep 30 2021 | n/a | n/a | -UK£7m |
| Jun 30 2021 | n/a | n/a | -UK£8m |
| Mar 31 2021 | n/a | n/a | -UK£15m |
| Dec 31 2020 | UK£193k | UK£175k | -UK£22m |
| Jun 30 2020 | n/a | n/a | -UK£22m |
| Mar 31 2020 | n/a | n/a | -UK£16m |
| Dec 31 2019 | UK£207k | UK£50k | -UK£9m |
Compensation vs Market: Stephen's total compensation ($USD296.50K) is about average for companies of similar size in the UK market ($USD349.05K).
Compensation vs Earnings: Stephen's compensation has been consistent with company performance over the past year.
CEO
Stephen Stamp (60 yo)
3.6yrs
Tenure
UK£237,897
Compensation
Mr. Stephen A. Stamp serves as Chief Financial Officer and Director of Biodexa Pharmaceuticals Plc (formerly known as Midatech Pharma plc) since September 9, 2019. He serves as Chief Executive Officer at B...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | 3.6yrs | UK£237.90k | 0.0026% £ 93.7 | |
| Chief Scientific Officer | 1.8yrs | UK£236.68k | no data | |
| Vice President of Technology | 2.3yrs | no data | no data | |
| VP & Head of Clinical Operations | less than a year | no data | no data | |
| President of Midatech Pharma US Inc | 7.3yrs | no data | no data | |
| Group Financial Controller | no data | no data | no data |
2.3yrs
Average Tenure
57yo
Average Age
Experienced Management: BDRX's management team is considered experienced (2.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, CFO | 3.6yrs | UK£237.90k | 0.0026% £ 93.7 | |
| Senior Independent Non-Executive Director | 8.3yrs | UK£31.54k | 0.0029% £ 103.6 | |
| Non-Executive Chairman | less than a year | UK£43.84k | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Independent Non-Executive Director | 18.5yrs | UK£31.54k | 0.0012% £ 44.0 | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Chairman of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data | |
| Member of Scientific Advisory Board | no data | no data | no data |
6.0yrs
Average Tenure
63yo
Average Age
Experienced Board: BDRX's board of directors are considered experienced (6 years average tenure).